This investment case provides an overview of the landscape, advantages and continual advances being made to make Canada a desired destination for clinical trial investment.
It is a concise and credible resource, communicating Canada’s clinical trials advantages in terms of speed, quality and incentives.
“The CCTCC’s Clinical Trials Investment Case is an invaluable resource to showcase our world-class landscape and competitive advantages to conducting research in Canada. My team has already taken advantage of this comprehensive and professionally designed tool to communicate our “Canadian Advantage” with our Research & Development colleagues, and successfully attract clinical trial investments in Canada based on our unique combination of speed, quality, and incentives.”
Fran Paradiso-Hardy, PharmD, MSc
Senior Director, Astellas Medical Affairs, Canada
This resource will be updated on annual basis. If you have feedback and questions please email email@example.com